Publication Name	World Journal of Stem Cells
Manuscript ID	65738
Country	Jordan

Received	2021-03-14 23:42
Peer-Review Started	2021-03-15 00:52
To Make the First Decision
Return for Revision	2021-06-05 01:44
Revised	2021-06-15 21:58
Second Decision	2021-08-26 03:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-08-27 09:42
Articles in Press	2021-08-27 09:42
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-09-17 03:58
Publish the Manuscript Online	2021-09-18 09:35

ISSN	1948-0210 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Minireviews
Article Title	Mesenchymal stem cells and COVID-19: What they do and what they can do
Manuscript Source	Invited Manuscript
All Author List	Ejlal Abu-El-Rub, Ramada R Khasawneh, Fatimah Almahasneh, Zaid Altaany, Nesreen Bataineh, Hana Zegallai and Saravanan Sekaran
ORCID	Author(s) ORCID Number Ejlal Abu-El-Rub http://orcid.org/0000-0001-9217-2560 Ramada R Khasawneh http://orcid.org/0000-0003-3873-925X Fatimah Almahasneh http://orcid.org/0000-0002-8799-2721 Zaid Altaany http://orcid.org/0000-0002-3260-9078 Nesreen Bataineh http://orcid.org/0000-0003-1666-6854 Hana Zegallai http://orcid.org/0000-0001-9959-7318 Saravanan Sekaran http://orcid.org/0000-0002-2212-0180
Funding Agency and Grant Number
Corresponding Author	Ejlal Abu-El-Rub, PharmD, PhD, Assistant Professor, Department of Physiology and Pathophysiology, Yarmouk University, Shafiq Irshidat st, Irbid 21163, Jordan. ejlal.abuelrub@yu.edu.jo
Key Words	SARS-CoV-2; COVID-19; Mesenchymal stem cells; Inflammation; Acute respiratory distress syndrome; Pulmonary fibrosis; Pneumonia; Renal injury; Cardiovascular diseases; Regeneration; Anti-inflammatory
Core Tip	Coronavirus disease 2019 (COVID-19) pandemic continues its rampant spread as more vengeant strains emerged in many countries. Severe cases of COVID-19 have been complicated by respiratory failure and multiple organ dysfunction with high mortality rate. Mesenchymal stem cells regenerative and anti-inflammatory abilities can be an innovative approach in repairing the damaged organs and improve the survival rate for critically ill COVID-19 patients.
Publish Date	2021-09-18 09:35
Citation	Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337
URL	https://www.wjgnet.com/1948-0210/full/v13/i9/1318.htm
DOI	https://dx.doi.org/10.4252/wjsc.v13.i9.1318

Full Article (PDF)	WJSC-13-1318.pdf
Full Article (Word)	WJSC-13-1318.docx
Manuscript File	65738_Auto_Eited-JLW.docx
Answering Reviewers	65738-Answering reviewers.pdf
Audio Core Tip	65738-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	65738-Conflict-of-interest statement.pdf
Copyright License Agreement	65738-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	65738-Language certificate.pdf
Peer-review Report	65738-Peer-review(s).pdf
Scientific Misconduct Check	65738-Scientific misconduct check.pdf
Scientific Editor Work List	65738-Scientific editor work list.pdf